Company Name: Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. is engaged in the development of medicines for intractable diseases. The company’s pipeline includes multiple RNAi-based product candidates including treatments for chronic hepatitis B virus infection and liver disease associated with alpha-1 antitrypsin deficiency (AATD).

Ticker Symbol: ARWR (NASDAQ)

Company Website:

Social Media:

Arrowhead Research LinkedIn

Arrowhead Research Twitter

Headquarters: Pasadena, CA